TYRA 8-K 2026-11-10
Tyra Biosciences, Inc. (TYRA) 8-K dated 2026-11-10 — accession 0001193125-26-454474.
Tyra Biosciences, Inc. (TYRA) is a biotechnology company listed on US.
TYRA: Tyra Biosciences Reports Third Quarter 2026 Financial Results and Recen…
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Income-statement cache for TYRA is thin on this filing URL. We will not invent exhibit numbers.
Not investment advice. The TYRA SEC hub lists recent forms. The stock page is the research view.
- Guidance
- expects to report additional clinical results in 2027.
Why it matters
- expects to report additional clinical results in 2027.